ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,970.84
      -1.11%
      US Tech 100
      20,897.20
      -1.35%
      Dow Jones
      42,992.21
      -0.77%
      Brent Oil
      73.44
      0.00%
      Bitcoin
      94,800.58
      -0.36%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. CSE

      6. Defence Therapeutics Inc (DTC) Quote

      Defence Therapeutics Inc

      Defence Therapeutics Inc (DTC)

      Damstra Holdings Limited
      Solo Brands Inc
      Defence Therapeutics Inc
      0.64
      0.04
      (6.67%)
      Closed December 29 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.64
      Bid
      0.60
      Ask
      0.65
      Volume
      12,000
      0.60 Day's Range 0.65
      0.48 52 Week Range 2.55
      Previous Close
      0.60
      Open
      0.60
      Last Trade
      500
      @
      0.64
      Last Trade Time
      Average Volume (3m)
      25,464
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      DTC Latest News

      More News

      DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

       DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

      February 16 2022
      InvestorsHub NewsWire

      Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

        Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

      January 26 2022
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

      Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

      November 30 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

      DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

      November 23 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

       DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

      November 09 2021
      InvestorsHub NewsWire

      VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

        VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

      November 03 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

        DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

      October 13 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

          DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

      October 06 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

       DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

      September 29 2021
      InvestorsHub NewsWire

      DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

       DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

      September 20 2021
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.1223.07692307690.520.670.52192730.56844345CS
      40.0916.36363636360.550.670.49289820.52968947CS
      120.058.474576271190.590.670.49254640.56539552CS
      26-0.15-18.98734177220.790.960.48313040.65710959CS
      52-1.6-71.42857142862.242.550.48292961.05419895CS
      156-4.96-88.57142857145.65.650.48194632.071103CS
      260-1.11-63.42857142861.758.150.48185522.54062035CS

      DTC - Frequently Asked Questions (FAQ)

      What is the current Defence Therapeutics share price?
      The current share price of Defence Therapeutics is $ 0.64
      What is the 1 year trading range for Defence Therapeutics share price?
      Defence Therapeutics has traded in the range of $ 0.48 to $ 2.55 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MOSSMoss Genomics Inc
      $ 0.16
      (3,100.00%)
      		479.42k
      SESweet Earth Holdings Corporation
      $ 0.495
      (230.00%)
      		16.55k
      IZOIzotropic Corporation
      $ 0.115
      (187.50%)
      		81k
      ADPTAdaptogenics Health Corp
      $ 0.06
      (140.00%)
      		68k
      NIRVNirvana Life Sciences Inc
      $ 0.05
      (100.00%)
      		14k
      ENRTEnertopia Corp
      $ 0.005
      (-66.67%)
      		3.35k
      ETIEnviroMetal Technologies Inc
      $ 0.005
      (-50.00%)
      		59.45k
      KVMKingsview Minerals Ltd
      $ 0.005
      (-50.00%)
      		106k
      WBIOWPD Pharmaceuticals Inc
      $ 0.005
      (-50.00%)
      		200k
      PSPowerStone Metals Corp
      $ 0.04
      (-42.86%)
      		4k
      CHGXChitogenX Inc
      $ 0.01
      (-33.33%)
      		7.92M
      SXSt Georges Eco Mining Corp
      $ 0.05
      (-9.09%)
      		2.34M
      AIMLAl ML Innovations Inc
      $ 0.155
      (34.78%)
      		2.14M
      SCPEScope Technologies Corp
      $ 1.75
      (14.38%)
      		1.62M
      GURNGlobal Uranium Corp
      $ 0.92
      (5.75%)
      		1.45M

      DTC Discussion

      View Posts
      Man6677 Man6677 3 years ago
      Why are there no trades here ?

      Thank you !

      Great news today !
      👍️0
      newspopper newspopper 3 years ago
      Get in KITL .08-.10 news will be poppin
      👍️0
      newspopper newspopper 3 years ago
      Need more volume for Poppin action
      👍️0
      newspopper newspopper 3 years ago
      Looking for FDA Poppin news
      👍️0
      newspopper newspopper 3 years ago
      KITL news going to be poppin
      👍️0
      GOLDBUFFALO GOLDBUFFALO 3 years ago
      Seems to be a very interesting stock.
      👍️0

      Your Recent History

      CSE
      DTC
      Defence Therapeutics
      BIT
      UB4QB0
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads